Macquarie Group LTD Omega Therapeutics, Inc. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,227 shares of OMGA stock, worth $1,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,227Holding current value
$1,619% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OMGA
# of Institutions
71Shares Held
45.3MCall Options Held
36.9KPut Options Held
33.5K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$38.6 Million7.23% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$4.64 Million3.95% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$2.45 Million0.01% of portfolio
-
Artal Group S.A. Luxembourg, N41.32MShares$1.75 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$1.47 Million0.0% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $63.2M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...